Log in  First Connection?
  
EnglishJapaneseFrenchSpanishGerman

Oncology ImagingArchives

Pre-treatment prediction of microsatellite instability in colon cancer: a nomogram model combining clinicopathological features and pre-treatment CT-based radiomics
Oncology Imaging
 1 min.

 Published on 10/07/2026 |  Original article (Full-text)  | Wei, Meng et al. | BMC Medical Imaging. Volume 26(1).

Determining microsatellite instability (MSI) status in colon cancer is crucial for selecting treatment strategies in advanced stages. Thus, accurately identifying MSI status before treatment is essential. Objective: This study aims to evaluate the utility of nomogram model that integrates clinicopathological...

HTML version PDF version  Print abstract

Predictive value of the 68Ga-PSMA-11 PET/CT PRIMARY score for pathological upgrading in patients with ISUP Grade 1 prostate cancer and PSA < 20 ng/mL undergoing radical prostatectomy
Oncology Imaging
 1 min.

 Published on 03/07/2026 |  Original article (Full-text)  | Ciftci, Esra et al. | Annals of Nuclear Medicine. Volume 40(7).

Pathological upgrading is common in men with ISUP Grade Group (GG) 1 prostate cancer due to sampling limitations. Ga-PSMA-11 PET/CT is promising for characterizing tumor biology. The 5-point PRIMARY score, which considers uptake, focality, and location, has limited data on predicting occult high-grade...

HTML version PDF version  Print abstract

Prognostic value of tumour volume based on [18F]PSMA-1007 PET/CT in prostate cancer
Oncology Imaging
 1 min.

 Published on 26/06/2026 |  Original article (Full-text)  | Ingvar, Jacob et al. | European Journal of Hybrid Imaging. Volume 10(1).

Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) enables sensitive detection and staging of prostate cancer, yet its relationship with long-term survival remains unclear. This study aimed to assess whether total lesion volume (TLV) measured on [F]PSMA-1007...

HTML version PDF version  Print abstract

Integrating PET/CT into breast cancer care: a review of recent developments
Oncology Imaging
 1 min.

 Published on 19/06/2026 |  Original article (Full-text)  | Serin Moghrabi et al. | Expert Review of Anticancer Therapy 2025; 25(7): 771-86

Breast cancer (BC) is the most common malignancy in women, classified by histopathological type, grade, receptor status, and stage. PET/CT, particularly with F-FDG, plays a vital role in staging, detecting metastases, and assessing treatment response. This review explores the role of PET/CT in BC management...

HTML version PDF version  Print abstract